Education
About Us
Working with TipRanks
Follow Us
Vigil Neuroscience Inc (VIGL)
NASDAQ:VIGL
VIGL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.49 - $6.06
Previous CloseN/A
Volume101.11K
Average Volume (3M)193.94K
Market Cap
$77.94M
Enterprise Value-$14.03M
Total Cash (Recent Filing)$24.15M
Total Debt (Recent Filing)$303.00K
Price to Earnings (P/E)―
Beta0.96
Next Earnings
May 07, 2025EPS Estimate
-0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.07
Shares Outstanding46,671,535
10 Day Avg. Volume157,166
30 Day Avg. Volume193,945
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.18
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.16
Forecast
1Y Price Target
$15.00Price Target Upside798.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Vigil Neuroscience Inc News
---
Bulls Say, Bears Say
Bulls Say
Partnership PotentialThe likelihood that Vigil Neuroscience strikes a large Alzheimer's disease-focused partnership deal for VG-3927 before the Phase 2 study start is quite high.
Regulatory PathwayFDA had shown interest for a potential accelerated approval pathway for iluzanebart.
Bears Say
Market ReactionVigil Neuroscience's shares are trading higher on the news, but the current stock move understates the positivity of the data, suggesting potential for further growth.
Price Target AdjustmentRevisiting operational expense assumptions beyond 2025 reduces the price target to $14 from $17.
---
Ownership Overview
29.07% Insiders
2.80% Mutual Funds
32.83% Other Institutional Investors
33.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VIGL FAQ
What was Vigil Neuroscience Inc’s price range in the past 12 months?
Vigil Neuroscience Inc lowest stock price was $1.49 and its highest was $6.06 in the past 12 months.
What is Vigil Neuroscience Inc’s market cap?
Vigil Neuroscience Inc’s market cap is $77.94M.
When is Vigil Neuroscience Inc’s upcoming earnings report date?
Vigil Neuroscience Inc’s upcoming earnings report date is May 07, 2025 which is in 32 days.
How were Vigil Neuroscience Inc’s earnings last quarter?
Vigil Neuroscience Inc released its earnings results on Mar 13, 2025. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.533 by -$0.037.
Is Vigil Neuroscience Inc overvalued?
According to Wall Street analysts Vigil Neuroscience Inc’s price is currently Undervalued.
Does Vigil Neuroscience Inc pay dividends?
Vigil Neuroscience Inc does not currently pay dividends.
What is Vigil Neuroscience Inc’s EPS estimate?
Vigil Neuroscience Inc’s EPS estimate is -0.53.
How many shares outstanding does Vigil Neuroscience Inc have?
Vigil Neuroscience Inc has 46,671,535 shares outstanding.
What happened to Vigil Neuroscience Inc’s price movement after its last earnings report?
Vigil Neuroscience Inc reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.533. Following the earnings report the stock price went down -10.213%.
Which hedge fund is a major shareholder of Vigil Neuroscience Inc?
Currently, no hedge funds are holding shares in VIGL
---
Vigil Neuroscience Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$15.00 (798.20% Upside)
$15.00 (798.20% Upside)
Blogger Sentiment
Bullish
VIGL Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 338.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $28.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-52.14%
12-Months-Change
Fundamentals
Return on Equity
-89.69%
Trailing 12-Months
Asset Growth
-16.45%
Trailing 12-Months
Company Description
Vigil Neuroscience Inc
Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed on myeloid cells 2 (TREM2) which is in Phase I for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, as well as for the treatment of cerebral adrenoleukodystrophy and alzheimer's disease. The company also develops a small molecule TREM2 agonist suitable for oral delivery to treat common neurodegenerative diseases associated with microglial dysfunction. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Cambridge, Massachusetts.
---
VIGL Stock 12 Month Forecast
Average Price Target
$15.00
▲(798.20% Upside)
Technical Analysis
Alnylam Pharma
―
Biogen
―
Ionis Pharmaceuticals
―
SAGE Therapeutics
―
Denali Therapeutics
―
Best Analysts Covering VIGL
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-43.32%
reiterated a buy rating 24 days ago
Copying Paul Matteis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.32% per trade.
---